Form 8-K - Current report:
SEC Accession No. 0001104659-25-022193
Filing Date
2025-03-10
Accepted
2025-03-10 16:45:50
Documents
16
Period of Report
2025-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258583d1_8k.htm   iXBRL 8-K 32779
2 EXHIBIT 5.1 tm258583d1_ex5-1.htm EX-5.1 15925
3 EXHIBIT 10.1 tm258583d1_ex10-1.htm EX-10.1 233195
4 GRAPHIC tm258583d1_ex5-1img001.jpg GRAPHIC 3543
  Complete submission text file 0001104659-25-022193.txt   520227

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20250310.xsd EX-101.SCH 3012
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20250310_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20250310_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm258583d1_8k_htm.xml XML 3553
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 25724450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)